Loading…
BSX
BOSTON SCIENTIFIC CORPORATIONNYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2025-12-31
Price history
Interactive · live data via TradingView🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$73.1B
Enterprise Value$76.1B
Income$2.9B
Sales$20.1B
Book/sh$16.89
Cash/sh$1.48
Dividend TTM—
Payout0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$11.9B
2021
$12.7B
2022
$14.2B
2023
$16.7B
2024
$20.1B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| Gross Profit | $8.2B | $8.7B | $9.9B | $11.5B | $13.9B |
| Operating Income | $1.2B | $1.6B | $2.3B | $2.6B | $3.6B |
| Net Income | $1.0B | $698.0M | $1.6B | $1.8B | $2.9B |
| Diluted EPS | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |
| Operating Cash Flow | $1.9B | $1.5B | $2.5B | $3.4B | $4.5B |
| Free Cash Flow | $1.3B | $938.0M | $1.8B | $2.6B | $3.7B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
Follow the news. Follow the move.
BSX story timeline
Company updates and connected market context, with the dated price move attached.
2
Stories
0
Direct
COMMUNITY · $BSX0 theses
POST YOUR TAKE →Related Stocks
Loading peers…
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.